Prevention of Genetic Instability by Pomegranate in Ogg1/Myh Deficient Mice

石榴预防 Ogg1/Myh 缺陷小鼠的遗传不稳定性

基本信息

  • 批准号:
    7474436
  • 负责人:
  • 金额:
    $ 7.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Large numbers of cancers are linked to inheritance of susceptibility genes, especially for DNA repair. For example, alterations in OGG1 and MYH genes are associated with elevated risk of colorectal, lung, kidney and bladder cancer. Likewise, Ogg1/Myh deficient mice are prone to tumors. OGG1 and MYH genes are involved in the repair of oxidative DNA damage. Oxidative DNA damage can result in deleterious rearrangements in our genome leading to cancer. Therefore, antioxidants may reduce the level of oxidative DNA damage and rearrangements, hence prevent cancer. Pomegranate contains very high levels of antioxidants compared to other fruits and vegetables and may help reduce cancer risk. The goal of this pre-clinical pilot study is to understand whether pomegranate intake can reduce the level of genome rearrangements. Ogg1/Myh deficient mice will be treated with pomegranate extract (PomX) in their drinking water and genome rearrangements, including point mutations and deletions, will be determined in PomX treated mice and control mice receiving normal drinking water. If PomX reduces genome rearrangements, it will suggest that PomX may act as a cancer preventive agent. This pilot study would provide a justification to examine the long-term chemopreventive effect of PomX. These studies are significant to the mission of the National Institute of Health, because they will (i) advance our understanding of gene-nutrient interactions in the modulation of cancer risk, (ii) investigate the mechanisms of action of dietary antioxidants, and (iii) test a new strategy to prevent cancer in persons at increased genetic risk. This research could be transferred to the clinical setting for prevention of primary and recurrent cancers, especially in OGG1 and MYH mutation carriers. In addition, intake of pomegranate products could be recommended to help reduce cancer throughout the population.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ramune Reliene其他文献

Ramune Reliene的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ramune Reliene', 18)}}的其他基金

Prevention of Genetic Instability by Pomegranate in Ogg1/Myh Deficient Mice
石榴预防 Ogg1/Myh 缺陷小鼠的遗传不稳定性
  • 批准号:
    7588074
  • 财政年份:
    2008
  • 资助金额:
    $ 7.7万
  • 项目类别:
Prevention of Genetic Instability by Pomegranate in Ogg1/Myh Deficient Mice
石榴预防 Ogg1/Myh 缺陷小鼠的遗传不稳定性
  • 批准号:
    8011256
  • 财政年份:
    2008
  • 资助金额:
    $ 7.7万
  • 项目类别:

相似海外基金

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
集中化学预防剂存储库和化学支持
  • 批准号:
    10884587
  • 财政年份:
    2023
  • 资助金额:
    $ 7.7万
  • 项目类别:
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
集中化学预防剂存储库和化学支持
  • 批准号:
    10580657
  • 财政年份:
    2019
  • 资助金额:
    $ 7.7万
  • 项目类别:
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
集中化学预防剂存储库和化学支持
  • 批准号:
    10350518
  • 财政年份:
    2019
  • 资助金额:
    $ 7.7万
  • 项目类别:
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
集中化学预防剂存储库和化学支持
  • 批准号:
    9983325
  • 财政年份:
    2019
  • 资助金额:
    $ 7.7万
  • 项目类别:
Topic 386: Proof of Concept for a Topical MEK Inhibitor as a Chemopreventive Agent for Squamous Cell Carcinoma in High Risk Organ Transplant Patients
主题 386:局部 MEK 抑制剂作为高危器官移植患者鳞状细胞癌化学预防剂的概念验证
  • 批准号:
    10020607
  • 财政年份:
    2019
  • 资助金额:
    $ 7.7万
  • 项目类别:
Preclinical development of a chemopreventive agent, 4-methylumbelliferone(4-MU) HHSN2512015000361 TORFP: 2018-E07 PP: 9/17/18 to 9/16/19
化学预防剂 4-甲基伞形酮 (4-MU) 的临床前开发 HHSN2512015000361 TORFP: 2018-E07 PP: 9/17/18 至 9/16/19
  • 批准号:
    10006482
  • 财政年份:
    2018
  • 资助金额:
    $ 7.7万
  • 项目类别:
Emodin as a chemopreventive agent for breast cancer
大黄素作为乳腺癌的化学预防剂
  • 批准号:
    10524241
  • 财政年份:
    2018
  • 资助金额:
    $ 7.7万
  • 项目类别:
Antitumor effects of lifestyle drugs on colorectal cancer: Involvement of antihypertensive drug ARB as a novel chemopreventive agent
生活方式药物对结直肠癌的抗肿瘤作用:抗高血压药物 ARB 作为新型化学预防剂的参与
  • 批准号:
    18K11023
  • 财政年份:
    2018
  • 资助金额:
    $ 7.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Emodin as a chemopreventive agent for breast cancer - admin supp
大黄素作为乳腺癌的化学预防剂 - 行政支持
  • 批准号:
    10027034
  • 财政年份:
    2018
  • 资助金额:
    $ 7.7万
  • 项目类别:
Emodin as a chemopreventive agent for breast cancer
大黄素作为乳腺癌的化学预防剂
  • 批准号:
    9904128
  • 财政年份:
    2018
  • 资助金额:
    $ 7.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了